Grantham, Mayo, Van Otterloo & Co (GMO)’s LENSAR LNSR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,058
Closed -$60K 735
2021
Q4
$60K Sell
10,058
-19,467
-66% -$136K ﹤0.01% 676
2021
Q3
$232K Sell
29,525
-2,400
-8% -$19.5K ﹤0.01% 658
2021
Q2
$276K Sell
31,925
-3,778
-11% -$29.2K ﹤0.01% 671
2021
Q1
$259K Sell
35,703
-2,531
-7% -$19.7K ﹤0.01% 795
2020
Q4
$277K Buy
+38,234
New +$328K ﹤0.01% 761

Other funds holding LNSR

Grantham, Mayo, Van Otterloo & Co (GMO)'s LNSR Position: Q1 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of LENSAR (LNSR) in Q1 2022, closing a stake of 10,058 shares — an estimated $60K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LNSR in Q4 2020 and held it in 5 quarters. The position peaked at $277K in Q4 2020. 37 funds tracked by Wall St. Rank hold LNSR as of Q1 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining LENSAR position as of Q1 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,058 LENSAR shares in Q1 2022, an estimated $60K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LENSAR in Q4 2020 and held it in 5 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s LENSAR position peaked at $277K in Q4 2020.
  • 37 funds tracked by Wall St. Rank held LENSAR as of Q1 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2022, filed 13 May 2022.